{
    "id": 23956,
    "cites": 24,
    "cited_by": 0,
    "reference": [
        "Jason Abaluck, Jonathan Gruber, and Ashley Swanson. Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets. NBER Working Paper No. 20976, 2015.",
        "Abby Alpert, Mark Duggan, and Judith K Hellerstein. Perverse Reverse Price Competition: Average Wholesale Prices and Medicaid Pharmaceutical Spending. Journal of Public Economics, 108:44\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c62, 2013.",
        "Marika Cabral, Michael Geruso, and Neale Mahoney. Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage. NBER Working Paper No. 20470, 2014. Colleen Carey. Technological Change and Risk Adjustment: Benefit Design Incentives in Medicare Part D.",
        "Centers for Medicare and Medicaid Services. May 2017 Medicaid and Chip Application, Eligibility Determination, and Enrollment Report. Issue Brief, available online at https://www.medicaid.gov, 2017.",
        "Amitabh Chandra, Jonathan Gruber, and Robin McKnight. Patient Cost-Sharing and Hospitalization Offsets in the Elderly. The American Economic Review, 100(1):193\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c213, 2010.",
        "Vilsa Curto, Liran Einav, Jonathan Levin, and Jay Bhattacharya. Can Health Insurance Competition Work? Evidence from Medicare Advantage. NBER Working Paper No. 20818, 2014.",
        "Vilsa Curto, Liran Einav, Amy Finkelstein, Jonathan D Levin, and Jay Bhattacharya. Healthcare Spending and Utilization in Public and Private Medicare. NBER Working Paper No. 23090, 2017.",
        "D. Cutler, M. McClellan, and J. Newhouse. How Does Managed Care Do It? RAND Journal of Economics, 31(3):526\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c548, 2000.",
        "Christina M. Dalton, Gautam Gowrisankaran, and Robert Town. Salience, Myopia, and Complex Dynamic Incentives: Evidence from Medicare Part D. NBER Working Paper No. 21104, 2015.",
        "Mark Duggan. Does Contracting Out Increase the Efficiency of Government Programs? Evidence from Medicaid HMOs. Journal of Public Economics, 88(12):2549\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2572, 2004.",
        "Mark Duggan and Tamara Hayford. Has the Shift to Managed Care Reduced Medicaid Expenditures? Evidence from State and Local-Level Mandates. Journal of Policy Analysis and Management, 32(3): 505\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c535, 2013. Mark Duggan and Fiona Scott Morton. The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.",
        "Mark Duggan, Amanda Starc, and Boris Vabson. Who Benefits when the Government Pays More? PassThrough in the Medicare Advantage Program. Journal of Public Economics, 141:50\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c67, 2016.",
        "Liran Einav, Amy Finkelstein, and Paul Schrimpf. The Response of Drug Expenditures to Non-Linear Contract Design: Evidence from Medicare Part D. Quarterly Journal of Economics, 130(2):841\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c899, 2015.",
        "Liran Einav, Amy Finkelstein, and Maria Polyakova. Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D. NBER Working Paper No. 22277, 2016.",
        "Michael Geruso, Timothy J. Layton, and Daniel Prinz. Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges. NBER Working Paper No. 22832, 2016.",
        "Kathy Gifford, Julia Paradise, Vernon Smith, and Dyke Snipes. A Profile of Medicaid Managed Care Programs in 2010: Findings From a 50-State Survey. Issue Brief, The Henry J. Kaiser Family Foundation, available online at http://www.kff.org, 2011. S. P. Keehan, D. A. Stone, J. A. Poisal, G. A. Cuckler, A. M. Sisko, S. D. Smith, and J. M. Lizonitz. National Health Expenditure Projections, 201625: Price Increases, Aging Push Sector to 20 Percent of Economy.",
        "Kurt Lavetti and Kosali Simon. Strategic Formulary Design in Medicare Part D Plans. NBER Working Paper No. 22338, 2016.",
        "Medicaid and CHIP Payment and Access Commission. Medicaid Payment for Outpatient Prescription Drugs. Issue Brief, available online at https://www.macpac.gov, 2017.",
        "Jim Ross. Small Pharmacies Fight to Stay in Medicaid. Ocala Star-Banner, available online at http://www.ocala.com/news/20170402/small-pharmacies-fight-to-stay-in-medicaid, 2017.",
        "Fiona Scott Morton. The Strategic Response by Pharmaceutical Firms to the Medicaid Most-FavoredCustomer Rules. RAND Journal of Economics, 28(2), 1997.",
        "Mark Shepard. Hospital Network Competition and Adverse Selection: Evidence from the Massachusetts Health Insurance Exchange. NBER Working Paper No. 22600, 2016.",
        "Amanda Starc and Robert J Town. Internalizing Behavioral Externalities: Benefit Integration in Health Insurance. NBER Working Paper No. 21783, 2015.",
        "The Lewin Group. Projected Impacts of Adopting a Pharmacy Carve-In Approach Within Medicaid Capitation Programs. Issue brief, available online at http://www.lewin.com, 2011.",
        "Robert Town and Su Liu. The Welfare Impact of Medicare HMOs. RAND Journal of Economics, pages 719\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c736, 2003."
    ]
}